Eli Health Company

Answering massive and growing unmet needs, Eli's initial focus is to give women a no-compromise option to own their fertility and contraception decisions. The inconvenience of existing methods and associated side effects should now be a thing of the past. Eli enables women to take control of their health across their lives, by providing them with powerful information on their daily hormone profile.

Eli is a small at-home device to monitor hormones in saliva. An app powered by learning algorithms interprets user's actual hormone variations on any given day. With this powerful information, users know their precise fertile days. For couples who want to conceive, this data increases their chances significantly. For women who want a safe contraceptive method that’s hormone-free and non-invasive, Eli finally brings a no-compromise option.

Founded Date: 2019
Estimated Revenue: $1M to $10M
Total Funding: 6745890
Investors Number: 15
Employee Number: 1-10
Last Funding Type: Seed
Industry: Reproductive & Sexual Health
Headquarters: Montreal, Quebec, Canada
Funding Status: Seed
Last Funding Date: 2023-04-04